Pseudomonas aeruginosa - Still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 463-464

  Rolston, Kenneth V I ^a,b   Tarrand, Jeffrey J ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Department of Laboratory Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTRIAXONE; QUINOLONE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CANCER PATIENT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

EID: 0032777982     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520247     Document Type: Article

References (10)

1. 1. Koll SB, Brown AE. The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 1993;17(suppl 2):S322-8.
2. 2. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
3. 3. Escande MC, Herbrect R. Prospective study of bacteremia in cancer patients. Support Care Cancer 1998;6:273-80.
4. 4. Coullioud D, Van der Auwera P, Viot M, Lasset C. Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. Support Care Cancer 1993;1:34-46.
5. 5. Chatzinikolaou I, Abi-Said D, Tarrand JJ, Bodey GP, Samonis G. Recent experience in Pseudomonas aeruginosa: bacteremia in cancer patients [abstract no J-91]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997:305.
6. 6. Al-Bahar S, Pandita R, Dhabhar BN, Al-Bahar E. Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome. Support Care Cancer 1994;2:400-2.
7. 7. Spanik S, Stopkova K, Grausova S, Koren P, Sepesi J, Kremery V Jr. Post-operative bacteremia in cancer patients with solid tumors undergoing surgery: risk factors, etiology and outcome in 276 patients. Support Care Cancer 1997;5:336-8.
8. 8. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551-73.
9. 9. Rolston KVI, Rubenstein EB, Freifeld A. Early empiric antibiotic therapy for febrile neutropenic patients at low risk. Infect Dis Clin North Am 1996;10:223-47.
10. 10. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med 1985;145:1621-9.